✦ LIBER ✦

PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIA

✍ Scribed by J. Schelfhout; T. Kauf

Book ID: 119309132
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 57 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.351

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final results of a double-blind, placebo

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

✍ Paul J. Pockros; Lennox Jeffers; Nezam Afdhal; Zachary D. Goodman; David Nelson; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

## Interferon-␥1b (IFN-␥1b ) is a pleiotropic cytokine that displays antifibrotic, antiviral, and antiproliferative activity. A total of 502 patients with compensated liver disease and an Ishak fibrosis score of 4-6 were randomized in a double-blind, placebo-controlled study, and 488 of these pati

Clinical trial: a phase II, randomized s

Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

✍ S. G. LIM; N. LEUNG; H. W. L. HANN; G. K. K. LAU; C. TREPO; H. MOMMEJA-MARIN; C. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

474 A Decision Analytic Markov Model to

474 A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options With Chronic Hepatitis C Virus

✍ Saab, Sammy; Gordon, Stuart C.; Park, Haesuk; Ahmed, Aijaz; Younossi, Zobair M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A Decision Analytic Markov Model to Eval

A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options with Chronic Hepatitis C Virus Genotype 2 Infection

✍ Younossi, Z.M.; Gordon, S.; Saab, S.; Ahmed, A.; Cure, S.; Guerra, I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

502 Peginterferon alpha-2A (40KD) monoth

502 Peginterferon alpha-2A (40KD) monotherapy vs peginterferon alpha-2A and ribavirin in naïve patients with chronic hepatitis C: Preliminary results of the SMIEC II trial in patients with early viral clearance on peginterferon monotherapy

✍ P. Piccolo; B. Koehler Horst; F. Angelico; S. Gentile; S. Francioso; P. Tarquini 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 65 KB

PIN50 The Clinical Efficacy and Cost-Eff

PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS)

✍ E. Nikoglou; S. Humphreys; A. El khoury; S.A. Ferrante; C. O' Regan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB